Suven Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 21.81 Cr
as on 24-10-2024
- Company Age 35 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 239.04 Cr
as on 24-10-2024
- Revenue 28.13%
(FY 2023)
- Profit 44.47%
(FY 2023)
- Ebitda 80.23%
(FY 2023)
- Net Worth 79.30%
(FY 2023)
- Total Assets 76.92%
(FY 2023)
About Suven Life Sciences
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 530239 and on the National Stock Exchange(NSE) under SUVEN.
The Corporate was formerly known as Suven Synthesis Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 21.81 Cr.
The company has closed loans amounting to ₹239.04 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Suven Life Sciences Limited India are Mohan Mallarapu as CFO and Shrenik Soni as Company Secretary. Sudharani Jasti, Venkateswarlu Jasti, Seyed Hasnain, and Three other members serve as directors at the Company.
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Suven Life Sciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkateswarlu Jasti  | Managing Director | 04-Jan-2010 | Current |
| Mohan Mallarapu | CFO | 10-Jan-2020 | Current |
| Shrenik Soni | Company Secretary | 10-Jan-2020 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vajja Rao  | Director | 19-Feb-2024 | Current |
| Santanu Mukherjee | Director | 15-May-2018 | Current |
| Sudharani Jasti | Whole-Time Director | 04-Jan-2013 | Current |
| Seyed Hasnain | Director | 30-Apr-2010 | Current |
| Ananthasai Jasthi | Director | 14-Nov-2018 | Current |
Financial Performance and Corporate Structure Insights of Suven Life Sciences.
Suven Life Sciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.13% increase. The company also saw a substantial improvement in profitability, with a 44.47% increase in profit. The company's net worth Soared by an impressive increase of 79.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suven Life Sciences?
In 2023, Suven Life Sciences had a promoter holding of 69.56% and a public holding of 30.43%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sidsam Profeza Technologies India Private LimitedActive 17 years 7 monthsSeyed Hasnain is a mutual person
Suven Pharmaceuticals LimitedActive 6 years 1 monthVenkateswarlu Jasti and Vajja Rao are mutual person
The Federation Of Telangana Chambers Of Commerce And IndustryActive 59 years 11 monthsVenkateswarlu Jasti is a mutual person
Muthoot Housing Finance Company LimitedActive 14 years 9 monthsSantanu Mukherjee is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Bahrain And Kuwait Bsc Creation Date: 06 Dec 2012 | ₹6.00 Cr | Satisfied |
Bank Of Bahrain And Kuwait Bsc Creation Date: 24 Aug 2012 | ₹30.00 Cr | Satisfied |
Bank Of India Creation Date: 17 Feb 2011 | ₹22.63 Cr | Satisfied |
How Many Employees Work at Suven Life Sciences?
Suven Life Sciences has a workforce of 137 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suven Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suven Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
